CM Hospitalar S/A (BVMF:VVEO3)
Brazil · Delayed Price · Currency is BRL 0.8200
+0.0200 (2.50%)
At close: Sep 17, 2026
CM Hospitalar S/A Financials Overview
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,709 | 11,567 | 11,583 | 11,084 | 8,747 | 6,219 |
Revenue Growth | 1.96% | -0.14% | 4.51% | 26.72% | 40.65% | 40.91% |
Gross Profit Gross Profit Growth | 1,793 | 1,669 | 1,306 | 1,735 | 1,397 | 1,097 |
Operating Income Operating Income Growth | 613.45 | 528.89 | -814.99 | 638.13 | 516.89 | 495.3 |
Net Income Net Income Growth | 56.87 | 18.24 | -1,415 | 359.92 | 259.73 | 395.16 |
Earnings Per Share EPS Growth | 0.18 | 0.06 | -4.46 | 1.20 | 0.92 | 1.51 |
EPS Growth | - | - | - | 31.05% | -39.41% | 178.91% |
| Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Material Material Growth | 2,926 | 2,716 | 2,568 |
Others Others Growth | -91.75 | 119.36 | 95.01 |
Medicine Medicine Growth | 8,874 | 8,732 | 8,920 |
Total Total Growth | 11,709 | 11,567 | 11,583 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 450.96 | 658.56 | 1,130 | 1,001 | 2,016 | 2,204 |
Total Debt Total Debt Growth | 3,823 | 3,871 | 4,195 | 3,418 | 3,480 | 2,264 |
Net Cash (Debt) Net Cash Growth | -3,372 | -3,212 | -3,065 | -2,417 | -1,464 | -60.74 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -10.68 | -10.17 | -9.65 | -8.05 | -5.16 | -0.23 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 269.1 | 276.58 | 34.15 | -895.63 | 532.75 | 320.12 |
Capital Expenditures CapEx Growth | -43.44 | -45.49 | -81.62 | -168.1 | -152.24 | -77.95 |
Free Cash Flow Free Cash Flow Growth | 225.66 | 231.09 | -47.47 | -1,064 | 380.51 | 242.16 |
Free Cash Flow Growth | - | - | - | - | 57.13% | 77.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.31% | 14.43% | 11.27% | 15.65% | 15.97% | 17.64% |
Operating Margin | 5.24% | 4.57% | -7.04% | 5.76% | 5.91% | 7.96% |
Pretax Margin | 0.34% | 0.39% | -13.74% | 1.25% | 2.38% | 6.57% |
Profit Margin | 0.49% | 0.16% | -12.22% | 3.25% | 2.97% | 6.35% |
FCF Margin | 1.93% | 2.00% | -0.41% | -9.60% | 4.35% | 3.89% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.137 | 0.277 | 0.405 |
Dividend Per Share Growth | -50.69% | -31.57% | - |
Dividend Yield | 1.01% | 1.76% | 2.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.55 | 24.59 | - | 12.41 | 17.60 | 13.66 |
Forward PE | 11.51 | 13.46 | 18.64 | 10.04 | 11.57 | 14.38 |
P/FCF Ratio | 1.15 | 1.94 | - | - | 12.01 | 22.30 |
PS Ratio | 0.02 | 0.04 | 0.06 | 0.40 | 0.52 | 0.87 |